V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210030965 | 210012041 | null | 41 | Palliative (P) | 2017-02-07 | 2017-02-14 | FCR | N | null | 210032755 | FCR |
| 210030966 | 210012053 | 1.9 | 56.6 | Palliative (P) | 2013-10-22 | 2014-06-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 210032781 | BENDAMUSTINE + RITUXIMAB |
| 210030967 | 210012056 | 1.68 | 40.2 | Palliative (P) | 2013-06-09 | 2013-06-09 | VINCRISTINE | N | N | 210032826 | VINCRISTINE |
| 210030968 | 210012060 | 1.64 | 0 | Curative (C) | 2013-09-10 | 2014-02-18 | ALL UKALL2003 TRIAL | Y | N | 210032841 | UKALL 2003 |
| 210030969 | 210012064 | 1.7 | 68.9 | Curative (C) | 2014-09-29 | 2014-09-29 | Triple Intrathecal | N | N | 210032858 | TRIPLE INTRATHECAL |
| 210030970 | 210012067 | 2 | 56.3 | Curative (C) | 2012-12-09 | 2013-07-15 | IMATINIB | 02 | N | 210032895 | IMATINIB |
| 210030971 | 210012071 | null | 65 | Curative (C) | 2017-02-14 | 2017-07-05 | IDELALISIB + RITUXIMAB | N | N | 210032935 | IDELALISIB + RITUXIMAB |
| 210030972 | 210012075 | null | null | Curative (C) | null | 2017-03-26 | ALL UKALL2003 TRIAL | Y | N | 210032940 | UKALL 2003 |
| 210030973 | 210012077 | 1.61 | 64.2 | Curative (C) | 2015-03-28 | 2015-03-28 | IDELALISIB + RITUXIMAB | N | N | 210032943 | IDELALISIB + RITUXIMAB |
| 210030974 | 210021680 | 1.54 | 63.2 | Palliative (P) | 2018-10-19 | 2018-10-26 | METHOTREXATE | N | null | 210032956 | METHOTREXATE |
| 210030975 | 210021681 | 1.71 | 60.3 | Curative (C) | 2016-06-06 | 2016-10-25 | IMATINIB | N | N | 210032961 | IMATINIB |
| 210030976 | 210012083 | null | null | Palliative (P) | 2014-08-10 | 2014-10-09 | IDELALISIB + RITUXIMAB | Y | N | 210032967 | IDELALISIB + RITUXIMAB |
| 210030977 | 210027619 | 1.7 | 74.2 | Curative (C) | 2018-12-29 | 2018-12-29 | Triple Intrathecal | N | N | 210032998 | TRIPLE INTRATHECAL |
| 210030978 | 210012094 | 1.87 | 77.3 | Not known (9) | 2015-06-06 | 2015-07-14 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210033014 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210030979 | 210033514 | 1.66 | 53 | Adjuvant (A) | 2017-06-25 | 2017-06-25 | IDELALISIB + RITUXIMAB | Y | N | 210033030 | IDELALISIB + RITUXIMAB |
| 210030980 | 210027623 | null | null | Curative (C) | 2013-08-16 | 2013-10-22 | ALL UKALL60+ TRIAL | Y | null | 210033070 | UKALL60+ |
| 210030981 | 210027624 | 1.82 | 84.3 | Disease modification (D) | 2016-01-09 | 2016-02-17 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210033127 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210030982 | 210021697 | null | 76 | Curative (C) | 2014-05-07 | 2014-07-09 | ALL UKALL60+ TRIAL | 02 | null | 210033139 | UKALL60+ |
| 210030983 | 210021698 | null | null | Curative (C) | 2017-12-23 | 2018-01-14 | Triple / Double Intrathecal Therapy | Y | N | 210033143 | TRIPLE INTRATHECAL |
| 210030984 | 210027627 | 1.6 | 76.5 | Curative (C) | 2015-11-03 | 2015-11-10 | Triple Intrathecal | Y | N | 210033187 | TRIPLE INTRATHECAL |
| 210030985 | 210012125 | 1.85 | 0 | Disease modification (D) | 2016-08-10 | 2016-11-23 | METHOTREXATE | Y | N | 210033206 | METHOTREXATE |
| 210030986 | 210012128 | 1.58 | null | Curative (C) | 2016-09-23 | 2016-09-23 | IMATINIB | N | N | 210033216 | IMATINIB |
| 210030987 | 210027632 | 1.78 | 78 | Curative (C) | 2016-03-03 | 2016-11-21 | ALL UKALL60+ TRIAL | 2 | N | 210033250 | UKALL60+ |
| 210030988 | 210027634 | 1.59 | 113.95 | Curative (C) | 2018-10-06 | 2018-12-29 | CHLORAMBUCIL + RITUXIMAB | N | null | 210033270 | CHLORAMBUCIL + RITUXIMAB |
| 210030989 | 210021708 | 1.63 | 89.9 | Curative (C) | 2014-03-07 | 2014-04-22 | Triple Intrathecal | 01 | N | 210033272 | TRIPLE INTRATHECAL |
| 210030990 | 210012136 | 0 | 60 | null | 2013-06-18 | 2013-06-24 | METHOTREXATE | N | null | 210033293 | METHOTREXATE |
| 210030991 | 210012139 | 0 | null | null | 2013-11-08 | 2013-11-18 | METHOTREXATE | null | null | 210033299 | METHOTREXATE |
| 210030992 | 210012146 | 0 | 0 | Curative (C) | 2014-12-27 | 2015-02-07 | Triple Intrathecal | N | N | 210033319 | TRIPLE INTRATHECAL |
| 210030993 | 210012149 | 1.78 | 57.2 | Disease modification (D) | 2013-10-17 | 2014-05-03 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | N | 210033321 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210030994 | 210012151 | 1.86 | 110 | Curative (C) | 2018-02-14 | 2018-03-23 | METHOTREXATE | Y | N | 210033326 | METHOTREXATE |
| 210030995 | 210036141 | 1.47 | 78 | Curative (C) | 2014-06-11 | 2014-06-11 | METHOTREXATE | N | N | 210033370 | METHOTREXATE |
| 210030996 | 210012156 | 1.74 | 65 | Curative (C) | 2016-04-01 | 2016-04-05 | IMATINIB | 02 | N | 210033375 | IMATINIB |
| 210030997 | 210021730 | 0 | 71.3 | Curative (C) | 2015-01-01 | 2015-02-24 | ALL UKALL2003 TRIAL | 1 | N | 210033416 | UKALL 2003 |
| 210030998 | 210012171 | 1.6 | 71.5 | Curative (C) | null | 2017-08-28 | R Chlorambucil | null | null | 210033417 | CHLORAMBUCIL + RITUXIMAB |
| 210030999 | 210012173 | null | 57.8 | Curative (C) | 2018-09-02 | 2018-09-30 | IDELALISIB + RITUXIMAB | N | N | 210033439 | IDELALISIB + RITUXIMAB |
| 210031000 | 210027651 | 1.59 | 68 | Curative (C) | 2013-10-04 | 2013-10-14 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 210033449 | CHLORAMBUCIL + RITUXIMAB |
| 210031001 | 210012180 | null | 50.4 | Curative (C) | 2016-12-01 | 2017-02-18 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210033462 | CHLORAMBUCIL + RITUXIMAB |
| 210031002 | 210012185 | null | 60 | Curative (C) | 2015-02-24 | 2015-02-25 | ALL UKALL2003 TRIAL | 2 | N | 210033486 | UKALL 2003 |
| 210031003 | 210012187 | 1.4 | 80 | Palliative (P) | 2013-11-17 | 2014-04-09 | CHLORAMBUCIL + RITUXIMAB | N | N | 210033487 | CHLORAMBUCIL + RITUXIMAB |
| 210031004 | 210012191 | 1.74 | -1 | Curative (C) | 2018-03-11 | 2018-03-26 | Triple / Double Intrathecal Therapy | N | N | 210033503 | TRIPLE INTRATHECAL |
| 210031005 | 210012196 | 1.38 | 20.8 | Curative (C) | 2016-06-21 | 2016-06-29 | ALL UKALL60+ TRIAL | N | N | 210033509 | UKALL60+ |
| 210031006 | 210012197 | null | 53 | null | 2017-11-06 | 2017-11-12 | Imatinib 600mg | N | null | 210033512 | IMATINIB |
| 210031007 | 210027658 | 0 | 73.5 | Curative (C) | 2012-10-16 | 2013-03-16 | ALL UKALL2003 TRIAL | N | N | 210033533 | UKALL 2003 |
| 210031008 | 210021748 | 1.71 | 84 | null | 2017-12-18 | 2017-12-19 | METHOTREXATE | 2 | N | 210033568 | METHOTREXATE |
| 210031009 | 210012214 | 1.72 | 76 | Curative (C) | 2015-12-30 | 2015-12-30 | ALL UKALL2003 TRIAL | N | N | 210033611 | UKALL 2003 |
| 210031010 | 210012218 | 1.64 | 66.2 | Disease modification (D) | 2013-08-16 | 2016-05-15 | Triple Intrathecal | 02 | N | 210033621 | TRIPLE INTRATHECAL |
| 210031012 | 210021756 | null | 68.6 | null | 2016-12-02 | 2017-04-27 | METHOTREXATE | N | N | 210033652 | METHOTREXATE |
| 210031013 | 210012225 | 1.58 | 80 | Disease modification (D) | 2017-08-27 | 2017-09-24 | IDELALISIB + RITUXIMAB | N | null | 210033656 | IDELALISIB + RITUXIMAB |
| 210031014 | 210031271 | 1.88 | 68.3 | Curative (C) | 2015-06-27 | 2015-12-09 | METHOTREXATE | N | N | 210033690 | METHOTREXATE |
| 210031015 | 210012231 | 1.75 | null | Curative (C) | 2016-07-08 | 2016-07-08 | IDELALISIB + RITUXIMAB | 1 | N | 210033709 | IDELALISIB + RITUXIMAB |